Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 0.05 mL, 0.1 mL |
| Concentration | n/a |
| Applications | ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Synthesizes the second messagers cyclic ADP-ribose and nicotinate-adenine dinucleotide phosphate, the former a second messenger for glucose-induced insulin secretion. Also has cADPr hydrolase activity. Also moonlights as a receptor in cells of the immune system. |
| Immunogen | Immunogen: Recombinant human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 protein (46-300aa) Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-7048 / sc-7047 / sc-15362 |
| Other Names | [2'-phospho-ADP-ribosyl cyclase; 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase; 2'-phospho-cyclic-ADP-ribose transferase; ADP-ribosyl cyclase 1; ADPRC 1; Cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1; T10; CD38], [CD38; CD38; ADPRC1; ADPRC 1; ADPRC 1; cADPr hydrolase 1] |
| Gene, Accession # | [CD38], Gene ID: 952, NCBI: NP_001766.2, UniProt: P28907 |
| Catalog # | MBS1494359 |
| Price | $120, $160 |
| Order / More Info | Human ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies